Technology transfer professionals are at it again with todays launch of Apollo Therapeutics. Leading universities and PraxisUnico members Imperial College London, UCL (University College London) and the University of Cambridge compile investment fund of £40m with globad pharmaseutical companies AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation.

Read the full new story at here